Adagene (Adagene) Price-to-Tangible-Book : 1.47 (As of Apr. 26, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Adagene Price-to-Tangible-Book?

As of today (2024-04-26), Adagene's share price is $2.35. Adagene's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was $1.60. Hence, Adagene's Price to Tangible Book Ratio of today is 1.47.

The historical rank and industry rank for Adagene's Price-to-Tangible-Book or its related term are showing as below:

ADAG' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.69 Med: 1.21 Max: 2.25
Current: 1.47

During the past 6 years, Adagene's highest Price to Tangible Book Ratio was 2.25. The lowest was 0.69. And the median was 1.21.

ADAG's Price-to-Tangible-Book is ranked better than
67.87% of 1220 companies
in the Biotechnology industry
Industry Median: 2.67 vs ADAG: 1.47

A closely related ratio is called PB Ratio. As of today, Adagene's share price is $2.35. Adagene's Book Value per Sharefor the quarter that ended in Dec. 2023 was $1.60. Hence, Adagene's P/B Ratio of today is 1.47.

Adagene Price-to-Tangible-Book Historical Data

The historical data trend for Adagene's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adagene Price-to-Tangible-Book Chart

Adagene Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.25

0.69

1.21

Adagene Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial					2.25	0.80	0.69	0.78	1.21

Competitive Comparison of Adagene's Price-to-Tangible-Book

For the Biotechnology subindustry, Adagene's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Adagene's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Adagene's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Adagene's Price-to-Tangible-Book falls into.

Adagene Price-to-Tangible-Book Calculation

Adagene's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	2.35	/	1.599
	=	1.47

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Adagene Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Adagene's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Adagene (Adagene) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adagene Inc (NAS:ADAG) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

978:Germany

Address

Xinghu Street, Suzhou Industrial Park, 4th Floor, Building C14, No. 218, Jiangsu Province, Suzhou, CHN, 215123

Website

https://www.adagene.com

Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.